The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vogel, S. N.
Right arrow Articles by Malo, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vogel, S. N.
Right arrow Articles by Malo, D.
The Journal of Immunology, 1999, 162: 5666-5670.
Copyright © 1999 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: Functional Characterization of the Effect of the C3H/HeJ Defect in Mice that Lack an Lpsn Gene: In Vivo Evidence for a Dominant Negative Mutation1

Stefanie N. Vogel2,*, Dabney Johnson{dagger}, Pin-Yu Perera*, Andrei Medvedev*, Line Larivière{ddagger}, Salman T. Qureshi{ddagger} and Danielle Malo{ddagger},§

* Uniformed Services University of the Health Sciences, Bethesda, MD 20814; {dagger} Oak Ridge National Laboratories, Oak Ridge, TN 37831; and {ddagger} Department of Medicine and § Department of Human Genetics, McGill University, Montreal, Canada


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
A point mutation in the Tlr4 gene, which encodes Toll-like receptor 4, has recently been proposed to underlie LPS hyporesponsiveness in C3H/HeJ mice (Lpsd). The data presented herein demonstrate that F1 progeny from crosses between mice that carry a ~9-cM deletion of chromosome 4 (including deletion of LpsTlr4) and C3H/HeJ mice (i.e., Lps0 x Lpsd F1 mice) exhibit a pattern of LPS sensitivity, measured by TNF activity, that is indistinguishable from that exhibited by Lpsn x Lpsd F1 progeny and whose average response is "intermediate" to parental responses. Thus, these data provide clear functional support for the hypothesis that the C3H/HeJ defect exerts a dominant negative effect on LPS sensitivity; however, expression of a normal Toll-like receptor 4 molecule is apparently not required.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Following the initial characterization of the C3H/HeJ strain as LPS hyporesponsive ~30 years ago (1, 2), a large number of genetic analyses were conducted to identify the gene responsible for this trait reviewed in Refs. (3) and (4). Analysis of F1, F2, and backcross hybrids from crosses between LPS-responsive and LPS-hyporesponsive mice showed that the defective LPS responses of C3H/HeJ mice in vivo and in vitro were controlled by a single autosomal gene (5, 6, 7). Two alleles were assigned to the Lps gene in inbred mouse strains: Lpsd (defective)3 and Lpsn (normal) (6). Lpsd mice also exhibit greatly increased susceptibility to bacterial infections (reviewed in 3). Although a number of knockout mice exhibit mitigated responses to LPS (8), a mutation within Lps leads to the most profound state of LPS hyporesponsiveness described to date.

Lps was originally mapped to mouse mid-chromosome 4 by its linkage to Mup1 (major urinary protein-1) using BXH recombinant inbred strains (9, 10, 11). Additional mapping data positioned Lps on chromosome 4, between Mup1 proximally and Ps (polysyndactyly) distally at 6 ± 2 cM and 13 ± 7 cM, respectively (6), with inferred linkage to b, the brown coat color locus. F1 progeny derived from Lpsn/Lpsn x C3H/HeJ (Lpsd/Lpsd) crosses exhibit intermediate ("codominant") to fully responsive phenotypes, depending upon the particular measure of LPS sensitivity employed (12; reviewed in 3). The biological significance of a dominantly inherited response pattern (i.e., the F1 response is comparable to that of the Lpsn parental) vs one that is intermediate represents an area of controversy in the literature, yet both patterns of F1 responses have been reported, and at times even within the same study (12, 13, 14). In 1975, Coutinho et al. (14) suggested that an "intermediate" response pattern might suggest that: 1) half the cells can be activated by LPS and the other half lack a "triggering receptor," or 2) all cells can be activated, but at the doses tested only half the cells achieve a threshold for activation. However, the latter possibility was dismissed because they observed intermediate F1 responses, even at very high LPS concentrations. McGhee et al. (13) also addressed LPS dosage, the contribution of background genes unrelated to Lps, and assay sensitivity as potentially contributory factors.

The C57BL/10ScCR, and its progenitor strain, C57BL/10ScN, (15, 16, 17) were also identified as LPS hyporesponsive, and their defect mapped to the same chromosomal location on mouse chromosome 4 (16). The failure of C3H/HeJ x C57BL/10ScCR F1 mice to respond to LPS suggests that these two strains carry noncomplementary mutations (18). In contrast to the intermediate to full responsiveness seen in progeny from Lpsn/Lpsn x C3H/HeJ crosses, Lpsn/Lpsn x C57BL/10ScCR F1 progeny exhibit full Lpsn-like responsiveness only (16).

The Lps gene was recently cloned (19, 20) and shown to encode Tlr4 (Toll-like receptor 4), a member of the IL-1 receptor family (21). C3H/HeJ mice carry a missense point mutation within Tlr4 that results in a substitution of a highly conserved proline at position 712 by an histidine, whereas, the C57BL/10ScCR and C57Bl/10ScN strains fail to express Tlr4 mRNA (19, 20) due to a chromosomal deletion of the gene (20). However, no functional data for the mechanism by which this defect exerts its profound effects have been published to date. The C3H/HeJ missense mutation within Tlr4 has been hypothesized to exert a dominant negative action on normal Tlr4 expressed in Lpsn x Lpsd F1 mice, resulting in "codominant" or "intermediate" LPS sensitivity (19). Our data provide the first direct functional evidence that the C3H/HeJ defect indeed acts as a dominant negative mutation; however, the presence of a normal Tlr4 allele at Lps is not required for expression of a codominant response seen in F1 progeny.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Production of F1 mice and their genotyping

C3H/HeJ and C3H/OuJ mice were purchased from Jackson Laboratories (Bar Harbor, ME). The brown (b) locus on mouse chromosome 4 is a recessive mutation of the fancy mouse that encodes for a tyrosinase-related protein-1 (Tyrp1) (22, 23). Multiple alleles at the b locus have been recovered from radiation mutagenesis experiments at Oak Ridge National Laboratory (Oak Ridge, TN); many of these alleles are homozygous-lethal deletions (24, 25, 26). The two homozygous-lethal stocks used in this study were b11R30M, which carries a deletion encompassing both b and whirler [Df(b wi)], and b13R75M, which carries a more distal deletion including b and depilated [Df(b dep)]. The balancer chromosome for b11R30M carries the original b mutation incorporated into the Oak Ridge National Laboratory tester stock, which is homozygous for seven recessive mutations including nonagouti (a), brown (b), pink-eyed dilution (p), chinchilla (cch), dilute (d) short ear (se) and piebald spotting (s) (24). The b allele carries a point mutation that creates a b-specific 5.2-kb TaqI fragment recognized by hybridization to a subfragment (MT4.Pv.25) of the pMT4 cDNA clone, which is the product of the Tyrp1 gene (22, 27). The balancer chromosome for b13R75M carries white-based brown (Bw), a b allele associated with an inversion at the 5' end of Tyrp1. The probe pBw3.6 detects a Bw-specific 4.3-kB PstI fragment (I. Jackson, unpublished observation). To produce F1 mice that carried one of the lethal b deletions opposite a C3H/HeJ chromosome, b/b1130RM or Bw/b13R75M males were mated to C3H/HeJ (+/+ for b) females, and offspring were genotyped using Southern blots of tail DNAs. For the b11R30M segregants, deletion carriers (+/b11R30M) were identified as those not carrying the b-specific 5.2-kb TaqI fragment recognized by MT4.Pv.25; +/b13R75M segregants were those not carrying the 4.3-kb Bw-specific PstI fragment recognized by pBw3.6.

Haplotype mapping of DNA from b/b11R30M mice

DNA markers (sequence tag site (STS), microsatellite, and microclone probes) used in this analysis were derived from a 1.7-Mb genomic DNA contig encompassing the Lps locus that was constructed between flanking markers D4Nds9 and D4 Mit178 (Ref. 20 and our unpublished observations). To discriminate between the Lpsn and Lpsd allele at Tlr4, Tlr4-specific PCR primers (5'-GTGCCCCGCTTTCACCTCTG-3' and (5'-TCTAGACACTACCACAATAA-3') flanking the region containing the C to A transversion resulting in the Pro712His mutation were used to amplify genomic DNA from F1 mice. PCR products were then analyzed by single-strand conformation polymorphism (SSCP) (20). For PCR typing of simple sequence length polymorphism (SSLP) and SSCP markers, PCR reactions were performed in a total volume of 20 µl using a 20-ng aliquot of genomic DNA. One of the primers was end-labeled with ({gamma}-33P)ATP and T4 polynucleotide kinase. The cycling conditions were initial denaturation at 94°C for 3 min, 35 three-step cycles at 94°C for 1 min, 52°C for 30 s, and 72°C for 1 min, followed by a final cycle at 72°C for 7 min. Radiolabeled-PCR products were denatured and electrophoresed on either 7% polyacrylamide gels containing 7 M urea (SSLP) or on 6% polyacrylamide gels containing 5% glycerol (SSCP).

Measurement of TNF bioactivity in vivo

Parentals and F1 progeny were injected i.p. with 25 µg protein-free (<0.008%) Escherichia coli K235 LPS in 0.5 ml pyrogen-free saline. Mice were bled 90 min later. Serum TNF bioactivity was measured in a L929 cytotoxicity assay (28).

Measurement of NF-{kappa}B translocation in vitro

Thioglycollate-elicited macrophages derived from C3H/HeJ and C3H/OuJ mice were cultured as described (29). Following stimulation with LPS or human rIL-1ß (National Cancer Institute Biological Resources Branch, National Institutes of Health, Bethesda, MD), nuclear extracts were prepared and analyzed by EMSA (29).


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
"Brown deletion mutants," originally derived as a result of radiation mutagenesis studies, have large chromosome 4 deletions that encompass the brown coat color (b) gene (24, 25, 26), which is linked to Lps (6). These mice were generated in F1 animals from Oak Ridge inbred strains, C3H/RL and 101/RL, and must be maintained in a heterozygotic state with a normal, "balancer" copy of chromosome 4 to insure viability. The deletion exhibited by the b11R30M strain (~9 cM in size) was predicted to eliminate the Lps gene based on mapping data (12, 24), whereas an equivalently large deletion carried by the b13R75M strain should not affect expression of Lps because the proximal breakpoint of the b13R75M deletion is distal to the proximal breakpoint in b11R30M mice (24). Hence, when b/b11R30M (Lpsn/Lps0) mice are crossed with C3H/HeJ (Lpsd/Lpsd) mice, two genotypes at the Lps locus are predicted (Fig. 1Go): F1 progeny that are either heterozygotic (Lpsn/Lpsd) or hemizygous for expression of Lpsd (i.e., Lps0/Lpsd), due to a lack of an Lps allele on the deleted region of chromosome 4. Thus, half the progeny would be predicted to express intermediate to full LPS sensitivity (as reported for Lpsn x Lpsd F1 progeny; reviewed in 3), while the remaining progeny (Lps0/Lpsd) should be completely unresponsive due to the expression of a single, defective copy of Lpsd only. Conversely, in crosses with the control deletion mutant, b13R75M, all F1 mice would be expected to carry one copy of Lpsn, derived either from the "balancer" chromosome or from the chromosome that contained the deletion distal to Lps. To rule out the possibility that the b11R30M strain was a "skipper" mutation (i.e., a deletion mutation that retains a small segment of the original genome, and in this case, the Lpsn allele), additional fine mapping using 28 novel markers and four publicly available chromosome 4 probes was conducted to type DNA samples from the b/b11R30M strain (Fig. 2Go, A and B). All 32 DNA markers including Tlr4 were deleted in the b11R30M strain, but not in the b13R75M strain, suggesting that a "skipper" mutation was highly unlikely. In addition, additional F1 mice that were typed as Lpsd/Lps0 contained only the Pro to His mutation identified for the Lpsd allele, while Lpsn/Lpsd F1 mice expressed both alleles (Fig. 2GoC). This is evidenced by the fact that only two SSCP patterns, based on the distinctive migration of single stranded and double stranded PCR products, are observed among F1 progeny: one that is C3H/HeJ-like and one that is a combination of the C3H/HeJ and C3H/HeN or 101 patterns.



View larger version (21K):
[in this window]
[in a new window]
  		FIGURE 1. Breeding strategy for propagation of F1 progeny resulting from crosses of brown deletion mutant, b/b11R30M, and C3H/HeJ parental strains.

 


View larger version (57K):
[in this window]
[in a new window]
  		FIGURE 2. High-resolution mapping of the mouse chromosome 4 region containing the Lps locus. A, Linkage map of mouse mid-chromosome 4. The 0.9-cM region from D4Nds9 to D4 Mit178 is expanded for clarity. The recombinational distances between loci have been reported previously (20). The two brown deletions (11R30M and 13R75M), as defined by Bell et al. (26), are represented by boxes below the map. Dashes indicate that the distal end of the deletion is not represented on the map. B, Diagram of the 1.7-Mb chromosomal segment encompassing the Lps mutation. Informative DNA markers used in the analysis are ordered along the chromosome and consist of microsatellites (D4 Mit, D4Nds, and D4 Mcg markers), STSs (3f1, 3f3, 3b11, 3a4, 1h9, and 2b9), BAC-end clones (363o12-t7, 277i15-sp6, 277i15-t7, 256f23-t7), microclone (D4Rck137), and known gene (Tlr4). D4 Mcg47, D4 Mcg49, and D4 Mcg54 are located between 256f23-t7 and D4 Mcg6. C, SSCP analysis of Tlr4 genomic region carrying the C to A transversion resulting in the Pro to His substitution at position 712. Lane 1, C3H/HeJ; lane 2, C3H/HeN; lane 3, 101; lane 4, water; lanes 5 to 20 are F1 progeny issued from a b/b11R30M (His/-) and C3H/HeJ (Pro/Pro) cross. Bands identified by an arrow are C3H/HeJ-specific. Two SSCP patterns are observed among the F1 progeny and discriminate between His/Pro (lanes 5 to 13 and 15 to 18) and -/Pro (lanes 14, 19, and 20) genotypes.

 
Therefore, F1 progeny, generated by crossing the b/b11R30M or Bw/b13R75M strains with C3H/HeJ mice were genotyped for markers that distinguished "balancer" chromosome 4 from the copy of chromosome 4 that contained the deletion, as well as C3H/HeJ chromosome 4 markers. Parentals and F1 progeny were injected with LPS, and TNF bioactivity was measured in sera collected 90 min later. Fig. 3Go shows that, as expected, the C3H/HeJ Lpsd parental mice failed to exhibit any TNF induction, while both brown deletion parents responded to LPS to make TNF. However, each group of F1 mice, including the Lps0/Lpsd (b11R30M/Lpsd) progeny, gave an "intermediate" response (as evidenced by the similarities of the distribution of individual TNF responses among all four groups of F1 mice and a comparison of average TNF levels).



View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 3. In vivo TNF responses of parental and F1 progeny to LPS challenge. Parental and F1 mice were challenged with LPS, and the sera were analyzed for TNF bioactivity. The genotypes of the mice with respect to the Lps locus can be summarized as follows: C3H/HeJ (Lpsd/Lpsd), b/b11R30M (Lpsn/Lps0), Bw/b13R75M (Lpsn/Lpsn), b/C3H/HeJ (Lpsn/Lpsd), b11R30M/C3H/HeJ (Lps0/Lpsd), Bw/C3H/HeJ (Lpsn/Lpsd), b13R75M/C3H/HeJ (Lpsn/Lpsd). The numbers in parentheses indicate the numbers of mice responding with the same response when >1. The horizontal bar indicates the geometric mean of the responses.

 
These data allow for several conclusions. First, the presence of a normal Lpsn allele (e.g., Tlr4) is apparently not required for some degree of LPS responsiveness, as evidenced by the fact that Lps0/Lpsd F1 mice responded to LPS equivalently to Lpsn/Lpsd mice to produce TNF in vivo. These data raise the possibility that LPS signaling receptors in addition to TLR4 may exist and are consistent with the possible utilization of alternate TLR-like molecules as LPS signaling receptors. In this context, TLR2 has been shown in transfection studies to confer LPS-signaling to LPS-nonresponsive cells (30, 31). In addition, the wide range of LPS-induced TNF activity in both F1 crosses (Lpsn/Lpsd and Lps0/Lpsd) supports the presence of other segregating genes that might influence the TNF response to LPS. The finding that F1 progeny issued from crosses between mouse strains with Tlr4 deletions (e.g., C57BL/10ScN or C57BL/10ScCR) and C3H/HeJ mice fail to respond to LPS suggests that the genetic background of the brown deletion mice used in this study possess additional genes that compensate for the lack of Tlr4 or that their ~9-cM deletion eliminates other gene(s) that normally contribute to a suppressed TNF response (18). More importantly, the data suggest that the Lpsd mutation, when present as a single copy, in the absence or presence of the normal Lpsn allele, fails to exert the same degree of hyporesponsiveness as seen in mice that are homozygous for Lpsd, suggesting a gene dosage effect for inhibition of LPS responsiveness (e.g., Lpsd exhibits a dominant negative effect on normal LPS responsiveness.)

Because the missense mutation lies in the intracytoplasmic domain of TLR4, it is possible that downstream adapter and signaling molecules (e.g., MyD88 and IRAK1 (21)), are sequestered by the defective molecule, precluding their engagement by alternate TLR molecules or other receptors that share these signaling components. Because TLR4 and the IL-1 receptor type I share signaling components (21), we measured IL-1 responsiveness in C3H/HeJ macrophages. Fig. 4Go shows that LPS induced NF-{kappa}B translocation in the C3H/OuJ (Lpsn) macrophages, but not in the C3H/HeJ macrophages, as previously reported (29, 32). However, the response to rIL-1ß was comparable in the two strains over a broad concentration range, consistent with an earlier observation that administration of rIL-1{alpha} to C3H/HeJ mice induced circulating CSF levels comparable to those observed in Lpsn mice (33). Hence, the C3H/HeJ defect in TLR4 does not preclude normal IL-1 responsiveness. Whether the defective TLR4 serves as a "decoy" receptor (i.e., it binds ligand, yet fails to signal in Lpsd/Lpsd cells), analogous to the type II IL-1 receptor (34), or exerts its inhibitory effect by forming nonsignaling complexes with functional homologous or heterologous TLR molecules, are other potential mechanisms.



View larger version (76K):
[in this window]
[in a new window]
  		FIGURE 4. Comparison of NF-{kappa}B translocation induced in macrophages derived from Lpsn (C3H/OuJ) and Lpsd (C3H/HeJ) mice. Macrophages were stimulated with rIL-1ß or LPS. NF-{kappa}B translocation was measured in nuclear extracts by EMSA. The results represent one of two separate experiments.

 


   Footnotes
 
1 This work was supported by National Institutes of Health Grant AI-18797 (S.N.V.) and Medical Research Council of Canada Grant MT-12038 (D.M.). S.T.Q. is a recipient of a Clinician Scientist Award from Medical Research Council and a career award in the Biomedical Sciences from the Burroughs Wellcome Fund. D.M. is a scholar from Fonds de la Recherche en Santé du Québec. Back

2 Address correspondence and reprint requests to Dr. Stefanie N. Vogel, Department of Microbiology and Immunology, Uniformend Services University of Health Sciences, 4301 Jones Bridge Road, B103, Bethesda, MD 20814-4799. E-mail address: Back

3 Abbreviations used in this paper: Lpsd, defective Lps gene; Lpsn, normal Lps gene; Mup1, major urinary protein-1 gene; Ps, polysyndactyly gene; b, brown coat color locus; Tyrp1, tyrosinase-related protein-1 gene; Bw, white-based brown b allele; TLR, Toll-like receptor; STS, sequence tag site; SSLP, simple sequence length polymorphism; SSCP, single-strand conformation polymorphism. Back

Received for publication January 28, 1999. Accepted for publication March 15, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Heppner, G., D. W. Weiss. 1965. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J. Bacteriol. 90:696.[Abstract/Free Full Text]
  2. Sultzer, B. M.. 1968. Endotoxin-induced resistance to a staphylococcal infection: cellular and humoral responses compared in two mouse strains. J. Infect. Dis. 118:340.[Medline]
  3. Vogel, S. N.. 1992. The Lps gene: insights into the genetic and molecular basis of LPS responsiveness and macrophage differentiation. B. Beutler, ed. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine 485.-513. Raven Press, New York.
  4. Vogel, S. N., N. Bhat, S. T. Qureshi, D. Malo. 1999. Genetic control of endotoxin responsiveness: the Lps gene revisited. D. C. Morrison, and H. Brade, and S. M. Opal, and S. N. Vogel, eds. Endotoxin in Health and Disease 735.-750. Marcel Dekker, New York.
  5. Watson, J., R. Riblet. 1974. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J. Exp. Med. 140:1147.[Abstract]
  6. Watson, J., K. Kelly, M. Largen, B. A. Taylor. 1978. The genetic mapping of a defective LPS response gene in C3H/HeJ. J. Immunol. 120:422.[Abstract/Free Full Text]
  7. Rosenstreich, D. L., S. N. Vogel, A. R. Jacques, L. M. Wahl, J. J. Oppenheim. 1978. Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J. Immunol. 121:1664.[Abstract/Free Full Text]
  8. Gutierrez-Ramos, J. C., H. Bluethmann. 1997. Molecules and mechanisms operating in septic shock: lessons from knockout mice. Immunol. Today 19:329.
  9. Watson, J., R. Riblet, B. A. Taylor. 1977. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J. Immunol. 118:2088.[Abstract/Free Full Text]
  10. Watson, J., M. Largen, K. P. W. J. McAdam. 1978. Genetic control of endotoxic responses in mice. J. Exp. Med. 147:39.[Abstract/Free Full Text]
  11. Fultz, M. J., and S. N. Vogel. The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. 1989. J. Immunol. 143:3001.
  12. Qureshi, S., L. Larivière, G. Sebastiani, S. Clermont, E. Skamen, P. Gros, D. Malo. 1996. A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics 31:283.[Medline]
  13. McGhee, J. R., S. M. Michalek, R. N. Moore, S. E. Mergenhagen, D. L. Rosenstreich. 1979. Genetic control of in vivo sensitivity to lipopolysaccharide: evidence for codominant inheritance. J. Immunol. 122:2052.[Abstract/Free Full Text]
  14. Coutinho, A., G. Möller, E. Gronowicz. 1975. Genetic control of B-cell responses. IV. Inheritance of the unresponsiveness to lipopolysaccharides. J. Exp. Med. 142:253.[Abstract/Free Full Text]
  15. McAdam, K. P. W. J., J. L. Ryan. 1978. C57BL/10CR mice: nonresponders to activation by the lipid A moiety of bacterial lipopolysaccharide. J. Immunol. 120:249.[Abstract/Free Full Text]
  16. Coutinho, A., T. Meo. 1978. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 7:17.
  17. Vogel, S. N., C. T. Hansen, D. L. Rosenstreich. 1979. Characterization of a congenitally LPS-resistant, athymic mouse strain. J. Immunol. 122:619.[Abstract/Free Full Text]
  18. Watson, J., K. Kelly, C. Whitlock. 1980. Genetic control of endotoxin sensitivity. D. Schlessinger, ed. Microbiology 1980 4.-10. American Society of Microbiology, Washington, D.C.
  19. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in tlr4 gene. Science 282:2085.
  20. Qureshi, S.T., L. Larivière, G. Leveque, S. Clermont, K. J. Moore, P. Gros, D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615.[Abstract/Free Full Text]
  21. O’Neill, L. A. J., C. Greene. 1998. Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J. Leukocyte Biol. 63:650.[Abstract]
  22. Jackson, I.. 1988. A cDNA encoding tyrosinase-related protein maps to the brown locus in mouse. Proc. Natl. Acad. Sci. USA 85:4392.[Abstract/Free Full Text]
  23. Tsukomoto, K., I. J. Jackson, K. Urabe, P. Montague, V. Hearing. 1992. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J. 11:519.[Medline]
  24. Rinchik, E. M., J. A. Bell, P.R. Hunsicker, J. M. Friedman, I. J. Jackson, L. B. Russell. 1994. Molecular genetics of the brown (b)-locus of mouse Chromosome 4. I. Origin and molecular mapping of radiation- and chemical-induced lethal brown deletions. Genetics 137:845.[Abstract]
  25. Rinchik, E. M.. 1994. Molecular genetics of the brown (b)-locus of mouse Chromosome 4. II. Complementation analyses of lethal brown deletions. Genetics 137:855.[Abstract]
  26. Bell, J. A., E. M. Rinchik, S. Raymond, R. Suffolk, I. J. Jackson. 1995. A high-resolution map of the brown (b, Tyrp1) deletion complex of mouse Chromosome 4. Mamm. Genome 6:389.[Medline]
  27. Shibahara, S., Y. Yomita, T. Sakahura, C. Nager, B. Chaudhuri, R. Muller. 1986. Cloning and expression of cDNA endcoding mouse tyrosinase. Nucleic Acids Res. 14:2413.[Abstract/Free Full Text]
  28. Hogan, M. M., S. N. Vogel. 1990. Measurement of tumor necrosis factor {alpha} and ß. J. E. Coligan, and A. M. Kruisbeek, and D. H. Margulies, and E. M. Shevach, and W. Strober, eds. Current Protocols in Immunology, Vol. 1 6.10.1. Greene Publishing Associates and Wiley Interscience, New York.
  29. Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-{kappa}B activation and TNF production induced by lipopolysaccharide and Group B streptococcal cell walls. J. Immunol. 160:4535.[Abstract/Free Full Text]
  30. Yang, R.-B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.[Medline]
  31. Kirschning, C. J., H. Wesche, T. M. Ayers, M. Rothe. 1998. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:2091.[Abstract/Free Full Text]
  32. Perera, P.-Y., N. Qureshi, S. N. Vogel. 1996. Paclitaxel (Taxol)-induced NF-{kappa}B translocation in murine macrophages. Infect. Immun. 64:878.[Abstract]
  33. Vogel, S. N., S. D. Douches, E. N. Kaufman, R. Neta. 1987. Induction of colony stimulating factor in vivo by recombinant interleukin 1{alpha} and recombinant tumor necrosis factor {alpha}. J. Immunol. 138:2143.[Abstract]
  34. Dinarello, C. A.. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. S. Justice, D. A. Hunstad, P. C. Seed, and S. J. Hultgren
Filamentation by Escherichia coli subverts innate defenses during urinary tract infection
PNAS, December 26, 2006; 103(52): 19884 - 19889.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. R. A. Martins, S. M. B. Jeronimo, J. E. Donelson, and M. E. Wilson
Leishmania chagasi T-Cell Antigens Identified through a Double Library Screen
Infect. Immun., December 1, 2006; 74(12): 6940 - 6948.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Yang, V. Murthy, K. Schultz, J. B. Tatro, K. A. Fitzgerald, and D. Beasley
Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2334 - H2343.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. W. Balzary and T. M. Cocks
Lipopolysaccharide Induces Epithelium- and Prostaglandin E2-Dependent Relaxation of Mouse Isolated Trachea through Activation of Cyclooxygenase (COX)-1 and COX-2
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 806 - 812.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Totemeyer, M. Sheppard, A. Lloyd, D. Roper, C. Dowson, D. Underhill, P. Murray, D. Maskell, and C. Bryant
IFN-{gamma} Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2.
J. Immunol., April 15, 2006; 176(8): 4804 - 4810.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. S. Campbell, K. J. Riehle, J. T. Brooling, R. L. Bauer, C. Mitchell, and N. Fausto
Proinflammatory Cytokine Production in Liver Regeneration Is Myd88-Dependent, but Independent of Cd14, Tlr2, and Tlr4
J. Immunol., February 15, 2006; 176(4): 2522 - 2528.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. E. Rosenkranz, D. J. Schulte, L. M.A. Agle, M. H. Wong, W. Zhang, L. Ivashkiv, T. M. Doherty, M. C. Fishbein, T. J.A. Lehman, K. S. Michelsen, et al.
TLR2 and MyD88 Contribute to Lactobacillus casei Extract-Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease
Circulation, November 8, 2005; 112(19): 2966 - 2973.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Yang, D. Coriolan, V. Murthy, K. Schultz, D. T. Golenbock, and D. Beasley
Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1069 - H1076.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. J. Chong, A. Shimamoto, C. R. Hampton, H. Takayama, D. J. Spring, C. L. Rothnie, M. Yada, T. H. Pohlman, and E. D. Verrier
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 170 - 179.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. S. Weiss, B. Raupach, K. Takeda, S. Akira, and A. Zychlinsky
Toll-Like Receptors Are Temporally Involved in Host Defense
J. Immunol., April 1, 2004; 172(7): 4463 - 4469.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Andreakos, S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell
Distinct pathways of LPS-induced NF-{kappa}B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP
Blood, March 15, 2004; 103(6): 2229 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. E. Medvedev, A. Lentschat, D. B. Kuhns, J. C.G. Blanco, C. Salkowski, S. Zhang, M. Arditi, J. I. Gallin, and S. N. Vogel
Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections
J. Exp. Med., August 18, 2003; 198(4): 521 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Muroi, T. Ohnishi, S. Azumi-Mayuzumi, and K.-i. Tanamoto
Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide Preparations
Infect. Immun., June 1, 2003; 71(6): 3221 - 3226.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. C. J. Royle, S. Totemeyer, L. C. Alldridge, D. J. Maskell, and C. E. Bryant
Stimulation of Toll-Like Receptor 4 by Lipopolysaccharide During Cellular Invasion by Live Salmonella typhimurium Is a Critical But Not Exclusive Event Leading to Macrophage Responses
J. Immunol., June 1, 2003; 170(11): 5445 - 5454.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Pacheco, F. A. Bozza, R. N. Gomes, M. Bozza, P. F. Weller, H. C. Castro-Faria-Neto, and P. T. Bozza
Lipopolysaccharide-Induced Leukocyte Lipid Body Formation In Vivo: Innate Immunity Elicited Intracellular Loci Involved in Eicosanoid Metabolism
J. Immunol., December 1, 2002; 169(11): 6498 - 6506.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Muroi and K.-i. Tanamoto
The Polysaccharide Portion Plays an Indispensable Role in Salmonella Lipopolysaccharide-Induced Activation of NF-{kappa}B through Human Toll-Like Receptor 4
Infect. Immun., November 1, 2002; 70(11): 6043 - 6047.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Muroi, T. Ohnishi, and K.-i. Tanamoto
Regions of the Mouse CD14 Molecule Required for Toll-like Receptor 2- and 4-mediated Activation of NF-kappa B
J. Biol. Chem., October 25, 2002; 277(44): 42372 - 42379.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
S. Yasuda, M. Nagaki, and H. Moriwaki
Staphylococcal enterotoxin B induces hepatic injury and lethal shock in endotoxin-resistant C3H/HeJ mice despite a deficient macrophage response
Innate Immunity, August 1, 2002; 8(4): 253 - 261.
[Abstract] [PDF]

Home page
 J Med MicrobiolHome page
A. UEHARA, S. SUGAWARA, and H. TAKADA
Priming of human oral epithelial cells by interferon-{gamma} to secrete cytokines in response to lipopolysaccharides, lipoteichoic acids and peptidoglycans
J. Med. Microbiol., August 1, 2002; 51(8): 626 - 634.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Muroi, T. Ohnishi, and K.-i. Tanamoto
MD-2, a Novel Accessory Molecule, Is Involved in Species-Specific Actions of Salmonella Lipid A
Infect. Immun., July 1, 2002; 70(7): 3546 - 3550.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
G. Sebastiani, V. Blais, V. Sancho, S. N. Vogel, M. M. Stevenson, P. Gros, J.-M. Lapointe, S. Rivest, and D. Malo
Host Immune Response to Salmonella enterica Serovar Typhimurium Infection in Mice Derived from Wild Strains
Infect. Immun., April 1, 2002; 70(4): 1997 - 2009.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
B. K. Yoza, J. Y.-Q. Hu, and C. E. McCall
Inhibition of histone deacetylation enhances endotoxin-stimulated transcription but does not reverse endotoxin tolerance
Innate Immunity, April 1, 2002; 8(2): 109 - 114.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
K. Gomi, K. Kawasaki, Y. Kawai, M. Shiozaki, and M. Nishijima
Toll-Like Receptor 4-MD-2 Complex Mediates the Signal Transduction Induced by Flavolipin, an Amino Acid-Containing Lipid Unique to Flavobacterium meningosepticum
J. Immunol., March 15, 2002; 168(6): 2939 - 2943.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Rassa, J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross
Murine retroviruses activate B cells via interaction with toll-like receptor 4
PNAS, February 19, 2002; 99(4): 2281 - 2286.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. M. Szaba and S. T. Smiley
Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo
Blood, February 1, 2002; 99(3): 1053 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Lorenz, M. Jones, C. Wohlford-Lenane, N. Meyer, K. L. Frees, N. C. Arbour, and D. A. Schwartz
Genes other than TLR4 are involved in the response to inhaled LPS
Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1106 - L1114.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. O. Neilsen, G. A. Zimmerman, and T. M. McIntyre
Escherichia coli Braun Lipoprotein Induces a Lipopolysaccharide-Like Endotoxic Response from Primary Human Endothelial Cells
J. Immunol., November 1, 2001; 167(9): 5231 - 5239.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. T. Smiley, J. A. King, and W. W. Hancock
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
J. Immunol., September 1, 2001; 167(5): 2887 - 2894.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. T. Abreu, P. Vora, E. Faure, L. S. Thomas, E. T. Arnold, and M. Arditi
Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide
J. Immunol., August 1, 2001; 167(3): 1609 - 1616.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. B. Schromm, E. Lien, P. Henneke, J. C. Chow, A. Yoshimura, H. Heine, E. Latz, B. G. Monks, D. A. Schwartz, K. Miyake, et al.
Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line: A Point Mutation in a Conserved Region of MD-2 Abolishes Endotoxin-induced Signaling
J. Exp. Med., July 2, 2001; 194(1): 79 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
C. Alexander and E. Th. Rietschel
Invited review: Bacterial lipopolysaccharides and innate immunity
Innate Immunity, June 1, 2001; 7(3): 167 - 202.
[Abstract] [PDF]